One-year shifts in North Star Ambulatory Assessment items in Duchene muscular dystrophy (DMD) patients in the UK NorthStar Network database View the Full PDF
The collaborative Trajectory Analysis Project (cTAP) – pioneering collaborative analytics for more effective clinical trials in Duchenne Muscular Dystrophy View the Full PDF
DEFLAZACORT OR PREDNISONE TREATMENT FOR DUCHENNE MUSCULAR DYSTROPHY (DMD): REAL-WORLD OUTCOMES AT CINCINNATI CHILDREN’S HOSPITAL MEDICAL CENTER (CCHMC) View the Full PDF
Consistency of 48-week changes in North Star Ambulatory Assessment (NSAA) between Duchenne muscular dystrophy (DMD) natural history data and clinical trial placebo arms, after adjustment for prognostic factors View the Full PDF
ESTIMATING CLINICALLY MEANINGFUL CHANGE THRESHOLDS IN THE NORTH STAR AMBULATORY ASSESSMENT (NSAA) AND FOUR-STAIR CLIMB (4SC) IN DUCHENNE MUSCULAR DYSTROPHY (DMD) View the Full PDF
Changes in Four-Stair Climb (4SC) over Two Years in Duchenne Muscular Dystrophy (DMD): Consistency across Data Sources and Prognostic Factors View the Full PDF